Genetic Background of Catecholaminergic Polymorphic Ventricular Tachycardia in Japan-Reference-Cited by-同舟云学术

Genetic Background of Catecholaminergic Polymorphic Ventricular Tachycardia in Japan

Published:2013 Issue:7 Volume:77 Page:1705-1713
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Kawamura Mihoko¹,Ohno Seiko¹,Naiki Nobu¹,Nagaoka Iori¹,Dochi Kenichi¹,Wang Qi¹,Hasegawa Kanae¹,Kimura Hiromi¹,Miyamoto Akashi¹,Mizusawa Yuka¹,Itoh Hideki¹,Makiyama Takeru²,Sumitomo Naokata³,Ushinohama Hiroya⁴,Oyama Kotaro⁵,Murakoshi Nobuyuki⁶,Aonuma Kazutaka⁶,Horigome Hitoshi⁷,Honda Takafumi⁸,Yoshinaga Masao⁹,Ito Makoto¹,Horie Minoru¹

Affiliation:

1. Department of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science

2. Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine

3. Department of Pediatrics and Child Health, Nihon University School of Medicine

4. Department of Pediatric Cardiology, Fukuoka Children’s Hospital and Medical Center for Infectious Disease

5. Department of Pediatric Cardiology, Iwate Medical University Memorial Heart Center

6. Cardiovascular Division, Graduate School of Comprehensive Human Sciences, University of Tsukuba

7. Department of Pediatrics, Tsukuba University Hospital

8. Department of Pediatrics, Tokyo Women’s Medical University Yachiyo Medical Center

9. Department of Pediatrics, National Hospital Organization Kagoshima Medical Center

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/77/7/77_CJ-12-1460/_pdf

Reference35 articles.

1. 1. Swan H, Piippo K, Viitasalo M, Heikkilä P, Paavonen T, Kainulainen K, et al. Arrhythmic disorder mapped to chromosome 1q42-q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts. J Am Coll Cardiol 1999; 34: 2035–2042.

2. 2. Lahat H, Eldar M, Levy-Nissenbaum E, Bahan T, Friedman E, Khoury A, et al. Autosomal recessive catecholamine-or exercise-induced polymorphic ventricular tachycardia: Clinical features and assignment of the disease gene to chromosome 1p13-21. Circulation 2001; 103: 2822–2827.

3. 3. Leenhardt A, Lucet V, Denjoy I, Grau F, Ngoc DD, Coumel P. Catecholaminergic polymorphic ventricular tachycardia in children: A 7-year follow-up of 21 patients. Circulation 1995; 91: 1512–1519.

4. 4. Bhuiyan ZA, van den Berg MP, van Tintelen JP, Bink-Boelkens MT, Wiesfeld AC, Alders M, et al. Expanding spectrum of human RYR2-related disease: New electrocardiographic, structural, and genetic features. Circulation 2007; 116: 1569–1576.

5. 5. Sumitomo N, Sakurada H, Taniguchi K, Matsumura M, Abe O, Miyashita M, et al. Association of atrial arrhythmia and sinus node dysfunction in patients with catecholaminergic polymorphic ventricular tachycardia. Circ J 2007; 71: 1606–1609.

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Loss-of-function W4645R mutation in the RyR2-caffeine binding site: implications for synchrony and arrhythmogenesis;Cell Calcium;2024-11

2. Genetic and clinical characteristics of catecholaminergic polymorphic ventricular tachycardia in a Taiwanese nationwide cohort;Journal of the Formosan Medical Association;2024-08

3. Discovery and Structure–Activity Relationship of a Ryanodine Receptor 2 Inhibitor;Chemical and Pharmaceutical Bulletin;2024-04-22

4. Application and validation of phenotype-enhanced variant classification in East Asian patients with catecholaminergic polymorphic ventricular tachycardia;Heart Rhythm;2023-12

5. Ethnic and racial differences in Asian populations with ion channelopathies associated with sudden cardiac death;Frontiers in Cardiovascular Medicine;2023-08-04